CD26-antigen-inhibitorsBullous pemphigoid: 17 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2020年 / 1819卷 / 1期

关键词：

D O I：

10.1007/s40278-020-82620-1

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：77 / 77

相关论文

共 50 条

[1] CD26 antigen inhibitorsBullous pemphigoid: 5 case reports
Reactions Weekly, 2018, 1697 (1) : 106 - 106
[2] CD26 antigen inhibitorsBullous pemphigoid: 8 case reports
Reactions Weekly, 2019, 1750 (1) : 72 - 72
[3] CD26-antigen-inhibitors/metforminBullous pemphigoid: 28 case reports
Reactions Weekly, 2019, 1778 (1) : 123 - 123
[4] Dipeptidyl-peptidase-4-inhibitorsBullous pemphigoid: 33 case reports
Reactions Weekly, 2023, 1987 (1) : 97 - 97
[5] Dipeptidyl peptidase-4 inhibitorsBullous pemphigoid: 23 case reports
Reactions Weekly, 2021, 1858 (1) : 143 - 143
[6] Saxagliptin/sitagliptin/vildagliptinMucous membrane pemphigoid: 17 case reports
Reactions Weekly, 2018, 1707 (1) : 246 - 246
[7] VildagliptinBullous pemphigoid: 2 case reports
Reactions Weekly, 2012, 1394 (1) : 41 - 41
[8] NivolumabBullous pemphigoid: 3 case reports
Reactions Weekly, 2018, 1698 (1) : 258 - 258
[9] LinagliptinBullous pemphigoid: 2 case reports
Reactions Weekly, 2016, 1591 (1) : 115 - 115
[10] VildagliptinBullous pemphigoid: 3 case reports
Reactions Weekly, 2015, 1538 (1) : 240 - 240

← 1 2 3 4 5 →